Rotigotine Schwarz Pharma
Mucke, H.A.M.
Idrugs the Investigational Drugs Journal 6(9): 894-899
2003
ISSN/ISBN: 1369-7056 PMID: 12964070 Document Number: 9845
Schwarz Pharma AG, under license from Aderis Pharmaceuticals Inc, is developing rotigotine CDS, a once-daily transdermal patch formulation of rotigotine, which is a naphthol-derived selective D, dopamine agonist, for the potential treatment of Parkinson's disease and restless legs syndrome.
Document emailed within 1 workday
